These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22130040)

  • 1. Increased membrane shedding--indicated by an elevation of CD133-enriched membrane particles--into the CSF in partial epilepsy.
    Huttner HB; Corbeil D; Thirmeyer C; Coras R; Köhrmann M; Mauer C; Kuramatsu JB; Kloska SP; Doerfler A; Weigel D; Klucken J; Winkler J; Pauli E; Schwab S; Hamer HM; Kasper BS
    Epilepsy Res; 2012 Mar; 99(1-2):101-6. PubMed ID: 22130040
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stem cell marker prominin-1/CD133 on membrane particles in human cerebrospinal fluid offers novel approaches for studying central nervous system disease.
    Huttner HB; Janich P; Köhrmann M; Jászai J; Siebzehnrubl F; Blümcke I; Suttorp M; Gahr M; Kuhnt D; Nimsky C; Krex D; Schackert G; Löwenbrück K; Reichmann H; Jüttler E; Hacke W; Schellinger PD; Schwab S; Wilsch-Bräuninger M; Marzesco AM; Corbeil D
    Stem Cells; 2008 Mar; 26(3):698-705. PubMed ID: 18096722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells.
    Marzesco AM; Janich P; Wilsch-Bräuninger M; Dubreuil V; Langenfeld K; Corbeil D; Huttner WB
    J Cell Sci; 2005 Jul; 118(Pt 13):2849-58. PubMed ID: 15976444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation of membrane particle-bound CD133 in cerebrospinal fluid of patients with subarachnoid and intracerebral hemorrhage.
    Bobinger T; Roeder SS; Spruegel MI; Froehlich K; Beuscher VD; Hoelter P; Lücking H; Corbeil D; Huttner HB
    J Neurosurg; 2020 Jan; 134(2):600-607. PubMed ID: 31978876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of neural stem cell surface marker CD133 in balloon cells of human focal cortical dysplasia.
    Ying Z; Gonzalez-Martinez J; Tilelli C; Bingaman W; Najm I
    Epilepsia; 2005 Nov; 46(11):1716-23. PubMed ID: 16302851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133-Positive Membrane Particles in Cerebrospinal Fluid of Patients with Inflammatory and Degenerative Neurological Diseases.
    Bobinger T; May L; Lücking H; Kloska SP; Burkardt P; Spitzer P; Maler JM; Corbeil D; Huttner HB
    Front Cell Neurosci; 2017; 11():77. PubMed ID: 28396625
    [No Abstract]   [Full Text] [Related]  

  • 8. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma.
    Song W; Li H; Tao K; Li R; Song Z; Zhao Q; Zhang F; Dou K
    Int J Clin Pract; 2008 Aug; 62(8):1212-8. PubMed ID: 18479363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of CD133 (AC133) and CD90 expression analysis for acute leukemia immunophenotyping.
    Wuchter C; Ratei R; Spahn G; Schoch C; Harbott J; Schnittger S; Haferlach T; Creutzig U; Sperling C; Karawajew L; Ludwig WD
    Haematologica; 2001 Feb; 86(2):154-61. PubMed ID: 11224484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD133: molecule of the moment.
    Mizrak D; Brittan M; Alison M
    J Pathol; 2008 Jan; 214(1):3-9. PubMed ID: 18067118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of pluripotent CD133+ cells correlates with malignancy of gliomas.
    Thon N; Damianoff K; Hegermann J; Grau S; Krebs B; Schnell O; Tonn JC; Goldbrunner R
    Mol Cell Neurosci; 2010 Jan; 43(1):51-9. PubMed ID: 18761091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma.
    Kohga K; Tatsumi T; Takehara T; Tsunematsu H; Shimizu S; Yamamoto M; Sasakawa A; Miyagi T; Hayashi N
    J Hepatol; 2010 Jun; 52(6):872-9. PubMed ID: 20395004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha2,3-Sialylation regulates the stability of stem cell marker CD133.
    Zhou F; Cui C; Ge Y; Chen H; Li Q; Yang Z; Wu G; Sun S; Chen K; Gu J; Jiang J; Wei Y
    J Biochem; 2010 Sep; 148(3):273-80. PubMed ID: 20551139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors.
    Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G
    J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midbody and primary cilium of neural progenitors release extracellular membrane particles enriched in the stem cell marker prominin-1.
    Dubreuil V; Marzesco AM; Corbeil D; Huttner WB; Wilsch-Bräuninger M
    J Cell Biol; 2007 Feb; 176(4):483-95. PubMed ID: 17283184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between endothelial progenitors cells and microparticles in HIV-infected patients naive for antiretroviral therapy.
    da Silva EF; Fonseca FA; França CN; Ferreira PR; Izar MC; Salomão R; Camargo LM; Tenore SB; Lewi DS
    AIDS; 2011 Aug; 25(13):1595-601. PubMed ID: 21673561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing spontaneous mobilization of CD34+ and CD133+ progenitor cells after myocardial infarction.
    Turan RG; Brehm M; Koestering M; Tobias Z; Bartsch T; Steiner S; Picard F; Ebner P; Schannwell CM; Strauer BE
    Eur J Clin Invest; 2007 Nov; 37(11):842-51. PubMed ID: 17973780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133 as a marker for cancer stem cells: progresses and concerns.
    Wu Y; Wu PY
    Stem Cells Dev; 2009 Oct; 18(8):1127-34. PubMed ID: 19409053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.